Genentech signs $515m breast cancer deal with Astex
By the numbers: The R&D deal with Roche’s Genentech is worth more than $515 million plus royalties and…
Vividion Therapeutics Announces Drug Discovery Collaboration with Roche Focused on Novel E3 Ligases
SAN DIEGO, May 19, 2020 /PRNewswire/ — Vividion Therapeutics, a biotechnology company discovering and developing highly selective small…
Novartis signs up to $1.9bn deal to tap Antares’ undruggable-target engine
Why it matters: The deal is a fresh validation point for Antares, a Scorpion Therapeutics spinout built around…
Novartis and Orionis get stuck in with new “molecular glue” R&D deal worth up to $1.4bn
The deal builds on the 2020 agreement between Orionis and Novartis where Ghent, Belgium-based Orionis made its debut.…
Roche offloads clinical-phase cancer drug to Celleron
Roche has offloaded its anti-CSF1R monoclonal antibody emactuzumab to Celleron Therapeutics. The licensing deal comes almost two years…
Roche bets on BTK degradation in $2.3bn Nurix deal
Under the agreement, Nurix will receive US$700m upfront and could earn development, regulatory and sales milestones bringing the…
Flare Therapeutics Announces Strategic Discovery Collaboration with Roche to Address Previously Undrugged Transcription Factor Targets in Oncology
Collaboration will leverage Flare Therapeutics’ proteomic and mass spectrometry platform and expertise, powered by its proprietary library of electrophilic…
MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to develop next-generation antibody drug conjugate in Oncology
SUZHOU, China, Jan. 2, 2024 /PRNewswire/ — MediLink Therapeutics (“MediLink”), announced today that it has entered into a worldwide…
Cote d’Ivoire: Eni and partners approve investment for Baleine Phase 3 in Côte d’Ivoire
During a ceremony held in Abidjan in the presence of the Minister of Mines, Petroleum and Energy of…
Verified Clinical Trials and Chubb Announce Strategic Alliance to Advance Research Subject Safety, Data Quality, and Clinical Trial Success
BOCA RATON, Fla., April 28, 2026 /PRNewswire/ — Verified Clinical Trials (VCT), the global leader in clinical trial subject…
OMass attracts $420m Roche wager on IBD programme
UK biotech OMass Therapeutics has revealed its first major pharma partnership, with Roche’s Genentech unit paying $20 million…